The Scientist

» drug development and immunology

Most Recent

Acute bouts of diarrhea could have lasting effects on the microbiota and host immune system activation, a mouse study suggests.

1 Comment

image: This Flu Season Killed 172 Kids

This Flu Season Killed 172 Kids

By Sukanya Charuchandra | June 11, 2018

Vaccination reduced the risk of death by two-thirds for children with no other health problems.  

0 Comments

The receptors, found in so-called elite controllers who don’t need medications to keep the virus in check, suggest a new path toward immunotherapy.

1 Comment

image: New Insights to Improve CAR T Cells’ Safety

New Insights to Improve CAR T Cells’ Safety

By Vicki Brower | June 5, 2018

Drugs approved to treat rheumatoid arthritis block cytokines, the molecules responsible for severe side effects from the immunotherapy, and reduce symptoms in mice.

0 Comments

image: A T-Cell Tweak Combats Advanced Breast Cancer

A T-Cell Tweak Combats Advanced Breast Cancer

By Ashley Yeager | June 5, 2018

The immunotherapy eliminated a woman’s metastatic lesions and kept her disease-free for two years.

0 Comments

image: Immunotherapy Drug Shows Promise for Melanoma, Lung Cancer

Immunotherapy Drug Shows Promise for Melanoma, Lung Cancer

By Sukanya Charuchandra | June 4, 2018

Merck’s Keytruda extended the lives of lung cancer patients by several months and appeared to stop the progression of advanced melanoma.  

0 Comments

Biotechs have developed enzyme replacements and genetically modified probiotics to treat patients with the rare metabolic disorder.

0 Comments

image: Image of the Day: Jasper the Cat

Image of the Day: Jasper the Cat

By The Scientist Staff | May 22, 2018

Researchers found a previously undiscovered hepadnavirus in an immunocompromised cat.

0 Comments

image: Immunotherapy More Effective in Men: Study

Immunotherapy More Effective in Men: Study

By Kerry Grens | May 18, 2018

Women with metastatic cancer who were treated with a checkpoint inhibitor had a smaller benefit than did men.

0 Comments

image: FDA Approves Drug to Ease Symptoms of Opioid Withdrawal

FDA Approves Drug to Ease Symptoms of Opioid Withdrawal

By Catherine Offord | May 17, 2018

Lucemyra is the first non-opioid drug to be approved in the U.S. specifically for this purpose.

0 Comments

Popular Now

  1. Two University of Rochester Professors Resign in Protest
  2. Dartmouth Professor Investigated for Sexual Misconduct Retires
  3. Theranos Leaders Indicted For Fraud
    The Nutshell Theranos Leaders Indicted For Fraud

    Federal prosecutors filed criminal charges that allege the company’s promise to revolutionize blood testing swindled investors out of hundreds of millions of dollars and put patients in danger.

  4. Koko the Signing Gorilla Dies at 46